000

CMG PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪286.12 B‬KRW
‪6.46 B‬KRW
‪93.91 B‬KRW
‪103.01 M‬
Beta (1Y)
0.80

About CMG PHARMACEUTICAL

CEO
Ju-Hyung Lee
Headquarters
Seoul
Employees (FY)
282
Founded
2001
ISIN
KR7058820002
FIGI
BBG000DB67W3
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. Its products include medicines in the form of tablets, capsules, and oral disintegrating films. The company was founded on August 1, 2001 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 058820 is 2060 KRW — it has decreased by 1.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CMG PHARMACEUTICAL stocks are traded under the ticker 058820.
058820 stock is 2.94% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is CMG PHARMACEUTICAL there?
Yes, you can track CMG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
058820 stock has fallen by 5.29% compared to the previous week, the month change is a 5.29% fall, over the last year CMG PHARMACEUTICAL has showed a 11.40% decrease.
058820 net income for the last quarter is ‪−2.65 B‬ KRW, while the quarter before that showed ‪2.71 B‬ KRW of net income which accounts for −197.77% change. Track more CMG PHARMACEUTICAL financial stats to get the full picture.
Today CMG PHARMACEUTICAL has the market capitalization of ‪286.12 B‬, it has decreased by 2.44% over the last week.
No, 058820 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 058820 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CMG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
058820 reached its all-time high on May 4, 2006 with the price of 15585 KRW, and its all-time low was 370 KRW and was reached on Apr 28, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 282.00 employees. See our rating of the largest employees — is CMG PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CMG PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CMG PHARMACEUTICAL stock shows the sell signal. See more of CMG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CMG PHARMACEUTICAL EBITDA is ‪5.59 B‬ KRW, and current EBITDA margin is 5.96%. See more stats in CMG PHARMACEUTICAL financial statements.